Background Investigation Methods, Corporate Intelligence & Due Diligence, e-Discovery Techniques, Investigation & Intelligence Feeds, Judgment Enforcement, Legal Enforcement Cases, Legal Ethics & Intelligence, Legal Technology & Intelligence, Witness Credibility Analysis

Hikma Announces Launch of Stelara® (ustekinumab) Biosimilar Starjemza™

Posted by

walter

November 17, 2025

On November 17, 2025

On November 6, 2025, Hikma announced the U.S. launch of Starjemza™ (ustekinumab-hmny), a biosimilar of Janssen / Johnson & Johnson’s Stelara® (ustekinumab). Starjemza™ is approved for all the reference product’s indications, including certain patients with plaque psoriasis, active psoriatic arthritis, Crohn’s disease, and ulcerative colitis….
By: Venable LLP